المؤلفون: Loke J; University of Birmingham, Birmingham, UK.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Labopin M; Acute Leukaemia Working Party, Paris Study Office, European Society for Blood and Marrow Transplantation, Paris, France.; Hematology Department, AP-HP, Sorbonne Universités, INSERM, Centre de Recherche Saint-Antoine (CRSA), Saint Antoine Hospital, Paris, France., Craddock C; Birmingham Centre for Cellular Therapy and Transplantation, Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.; University of Warwick, Warwick, UK., Socié G; Department of Hematology-BMT, Hopital St. Louis, Paris, France., Gedde-Dahl T; Hematology Department, Oslo University Hospital, Rikshospitalet Clinic for Cancer Medicine, Oslo, Norway., Blaise D; Programme de Transplantation & Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille, Marseille, France., Forcade E; CHU Bordeaux Hôpital Haut-leveque, Pessac, France., Salmenniemi U; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland., Huynh A; CHU-Institut Universitaire du Cancer Toulouse, Oncopole, Toulouse, France., Versluis J; Erasmus MC Cancer Institute University Medical Center, Rotterdam, Netherlands., Yakoub-Agha I; CHU de Lille, INSERM U995, Lille, France., Labussière-Wallet H; Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard, Lyon, France., Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Passweg J; University Hospital, Hematology, Basel, Switzerland., Bulabois CE; CHU Grenoble Alpes, Service d`Hématologie, Grenoble, France., Gabellier L; Département d`Hématologie Clinique, CHU Lapeyronie, Montpellier, France., Mielke S; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Castilla-Llorente C; Department of Hematology, Gustave Roussy Cancer Campus BMT Service, Villejuif, France., Deconinck E; Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Hématologie, CHU Besançon, Besançon, France., Brissot E; Hematology Department, AP-HP, Sorbonne Universités, INSERM, Centre de Recherche Saint-Antoine (CRSA), Saint Antoine Hospital, Paris, France., Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Ciceri F; Hematology and Bone Marrow Transplantation Unit, Università Vita Salute San Raffaele, Milan, Italy., Mohty M; Hematology Department, AP-HP, Sorbonne Universités, INSERM, Centre de Recherche Saint-Antoine (CRSA), Saint Antoine Hospital, Paris, France.

المصدر: Cancer [Cancer] 2024 Aug 01; Vol. 130 (15), pp. 2642-2651. Date of Electronic Publication: 2024 Apr 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/mortality , Remission Induction* , HLA Antigens*/immunology , Unrelated Donors* , Siblings*, Humans ; Male ; Middle Aged ; Adult ; Female ; Prognosis ; Adolescent ; Young Adult ; Aged ; Hematopoietic Stem Cell Transplantation/methods ; Induction Chemotherapy/methods ; Transplantation, Homologous

المؤلفون: Oshima N; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Hiraoka S; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Hayashi R; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Takahashi S; Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan., Ishii M; General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan., Hashimoto S; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Yashima K; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan., Igawa S; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Inokuchi T; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ueno Y; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Inaba T; Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan., Matsumoto H; Division of Gastroenterology, Kawasaki Medical School, Okayama, Japan., Kawashima K; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Takami T; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Isomoto H; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan., Shiotani A; Division of Gastroenterology, Kawasaki Medical School, Okayama, Japan., Tanaka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Ishihara S; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.

المصدر: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jul 03; Vol. 30 (7), pp. 1087-1093.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colitis, Ulcerative*/drug therapy , Tacrolimus*/administration & dosage , Tacrolimus*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/therapeutic use , Remission Induction*, Humans ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Severity of Illness Index ; Induction Chemotherapy ; Administration, Oral ; Treatment Outcome ; Mesalamine/administration & dosage ; Mesalamine/therapeutic use

المؤلفون: Tang FF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Duan WB; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Liu XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Lu SY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Jia JS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Gong LZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Zhao T; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Shi HX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China., Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.

المصدر: British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 510-516. Date of Electronic Publication: 2024 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Etoposide*/administration & dosage , Etoposide*/therapeutic use , Induction Chemotherapy*/methods , Leukemia, Promyelocytic, Acute*/drug therapy , Leukemia, Promyelocytic, Acute*/mortality, Humans ; Male ; Female ; Middle Aged ; Adult ; Administration, Oral ; Retrospective Studies ; Infusions, Intravenous ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; COVID-19 ; Tretinoin/administration & dosage ; Tretinoin/therapeutic use ; SARS-CoV-2 ; Remission Induction ; Arsenic/administration & dosage ; Aged

المؤلفون: Sajiki D; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, 3-35 Michishita-Cho, Nakamura-Ku, Nagoya, 453-8511, Japan., Muramatsu H; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Sakaguchi K; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan., Maeda N; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Yokoyama N; Department of Pediatric Hematology, Gifu Municipal Hospital, Gifu, Japan., Miyajima Y; Department of Pediatrics, Anjo Kosei Hospital, Anjo, Japan., Tanaka M; Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan., Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Hama A; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, 3-35 Michishita-Cho, Nakamura-Ku, Nagoya, 453-8511, Japan. hamaasahito@outlook.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 Jul; Vol. 120 (1), pp. 117-127. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Induction Chemotherapy*, Humans ; Child ; Male ; Child, Preschool ; Female ; Adolescent ; Infant ; Remission Induction ; Leukemia, Myeloid, Acute/therapy ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Survival Rate ; Prognosis ; Disease-Free Survival ; Retrospective Studies ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis

المؤلفون: Fulati W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Ma J; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Wu M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Qian W; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Chen P; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Hu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Chen M; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Xu Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Huang Z; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Zhang H; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Xie Y; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China., Shen L; Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 10; Vol. 15, pp. 1382189. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/therapy , Lymphoma, T-Cell, Peripheral*/mortality , Transplantation, Autologous* , Hematopoietic Stem Cell Transplantation*/adverse effects , Consolidation Chemotherapy* , Induction Chemotherapy*, Humans ; Female ; Male ; Middle Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Remission Induction ; Aged ; Retrospective Studies ; Young Adult ; Treatment Outcome ; Prognosis ; Combined Modality Therapy

المؤلفون: Liu H; Department of Hematology, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong, People's Republic of China.

المصدر: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2161194.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

مواضيع طبية MeSH: Induction Chemotherapy* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism, Humans ; Prognosis ; Remission Induction ; Retrospective Studies ; Histone-Lysine N-Methyltransferase

المؤلفون: Mohan BP; Gastroenterology & Hepatology, University of Utah Health, Salt Lake, City, Utah, USA., Fatima N; Gastroenterology & Hepatology, University of Utah Health, Salt Lake, City, Utah, USA., Khan SR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kassab L; Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Chandan S; Gastroenterology & Hepatology, Creighton University School of Medicine, Omaha, Nebraska, USA., Asokkumar R; Gastroenterology & Hepatology, Singapore General Hospital, Singapore., Valentine JF; Gastroenterology & Hepatology, University of Utah Health, Salt Lake, City, Utah, USA., Navaneethan U; Center for IBD, Orlando Digestive Institute, Orlando, Florida, USA., Kochhar GS; Center for Advanced Endoscopy & IBD, Allegheny Health Network, Pittsburgh, Pennsylvania, USA., Ma C; Gastroenterology, University of Calgary, Calgary, Alberta, Canada., Jairath V; Alimentiv Inc. London, Ontario, Canada.; Gastroenterology, Western University, London, Ontario, Canada., Singh S; Gastroenterology, University of California San Diego, La Jolla, California, USA.

المصدر: The American journal of gastroenterology [Am J Gastroenterol] 2023 Nov 01; Vol. 118 (11), pp. 2084-2087. Date of Electronic Publication: 2023 May 19.

نوع المنشور: Meta-Analysis; Systematic Review; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 0421030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-0241 (Electronic) Linking ISSN: 00029270 NLM ISO Abbreviation: Am J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Induction Chemotherapy* , Inflammatory Bowel Diseases*/drug therapy, Humans ; Remission Induction ; Causality

المؤلفون: Xu W; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Qiu L; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Li F; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Fei Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Wei Q; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Shi K; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Zhu Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Luo J; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Wu M; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Yuan J; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China., Liu H; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Mao J; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China., Cao Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. Electronic address: yuandongcao@163.com., Zhou S; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. Electronic address: zhoushu164086035@126.com., Guan X; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China; Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China. Electronic address: guanxin@cpu.edu.cn.

المصدر: Oral oncology [Oral Oncol] 2024 Jul; Vol. 154, pp. 106865. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis* , Nasopharyngeal Carcinoma*/drug therapy , Nasopharyngeal Carcinoma*/economics , Nasopharyngeal Carcinoma*/mortality , Induction Chemotherapy*/economics , Induction Chemotherapy*/methods , Network Meta-Analysis* , Nasopharyngeal Neoplasms*/drug therapy , Nasopharyngeal Neoplasms*/economics, Humans ; Quality-Adjusted Life Years ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/economics ; Cost-Effectiveness Analysis

المؤلفون: Tamsett Z; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia., Douglas N; Department of Anaesthesia, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia., King C; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia.; School of Medicine, Deakin University, Geelong, Victoria, Australia., Johnston T; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia., Bentley C; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia., Hao B; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia., Prinsloo D; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia., Bourke EM; Department of Emergency Medicine, Grampians Health, Ballarat, Victoria, Australia.; Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Emergency Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

المصدر: Emergency medicine Australasia : EMA [Emerg Med Australas] 2024 Jun; Vol. 36 (3), pp. 340-347. Date of Electronic Publication: 2023 Nov 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Pub Country of Publication: Australia NLM ID: 101199824 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-6723 (Electronic) Linking ISSN: 17426723 NLM ISO Abbreviation: Emerg Med Australas Subsets: MEDLINE

مواضيع طبية MeSH: Emergency Service, Hospital*/statistics & numerical data , Hypotension*/epidemiology , Hypotension*/drug therapy , Hypotension*/etiology , Rapid Sequence Induction and Intubation*/methods , Ketamine*/therapeutic use , Propofol*/adverse effects , Propofol*/therapeutic use , Propofol*/administration & dosage, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Incidence ; Fentanyl/therapeutic use ; Intubation, Intratracheal/methods ; Australia/epidemiology

المؤلفون: Zhang JL; Department of Gastroenterology, Eastern Health, Melbourne, VIC, Australia. Jenniferz1rafa@gmail.com., Vootukuru N; Department of Gastroenterology, Eastern Health, Melbourne, VIC, Australia., Niewiadomski O; Department of Gastroenterology, Eastern Health, Melbourne, VIC, Australia.; Monash University, Melbourne, VIC, Australia.

المصدر: BMC gastroenterology [BMC Gastroenterol] 2024 Aug 06; Vol. 24 (1), pp. 250. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article; Systematic Review; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease*/diet therapy , Crohn Disease*/therapy , Remission Induction*, Humans ; Quality of Life ; Enteral Nutrition/methods ; Adult ; Randomized Controlled Trials as Topic ; Child